Is Synjardy available as a generic, or only brand-name?
Synjardy (brand name for empagliflozin + metformin) is not listed as “generic Synjardy” in the usual sense. Instead, the market typically offers either the brand product or separate generic components (empagliflozin and metformin) and sometimes other fixed-dose combination products, depending on approvals and launches.
What does “generic Synjardy” mean for this drug?
Because Synjardy is a fixed-dose combination (empagliflozin plus metformin), a true “generic Synjardy” would require a generic version of the combination tablet at the same strength(s). If that specific combination is not available generically, patients and prescribers may use:
- the brand Synjardy, or
- individual generics (metformin + an SGLT2 inhibitor such as empagliflozin), or
- a different brand/generic fixed-dose combination product.
How can I check what’s available right now?
DrugPatentWatch tracks drug and patent information and is a common place to verify whether a generic version is expected/available and which companies may be involved. You can check Synjardy directly here: https://www.drugpatentwatch.com/
If no Synjardy generic exists, what are the closest alternatives?
If a fixed-dose “generic Synjardy” isn’t on the market, practical alternatives often include:
- metformin generic plus empagliflozin generic (taken as two pills), or
- another fixed-dose combination product that matches an SGLT2 inhibitor + metformin (availability varies by strength and location).
Does the answer depend on which Synjardy strength you take?
Yes. Even if one combination strength has a generic alternative (or is expected), other strengths may still be brand-only due to how patents/exclusivities cover specific formulations and dosing.
Sources
- https://www.drugpatentwatch.com/